Plenty of folks have been using GLP-1s — generic versions of popular weight loss drugs such as Ozempic and Zepbound — to jump ...

Ozempic and alcohol-use disorder were central to a recent study that showed the weight-loss drug helped decrease bingeing. Is ...

Medications like Ozempic and Mounjaro work by mimicking naturally occurring hormones in the body, such as glucagon-like ...

Ozempic: Contains Semaglutide, a GLP-1 receptor agonist. Mounjaro is not Insulin, it is a type of drug called a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 ...

Move over and make way for Mounjaro, the new ‘weight loss’ drug gaining popularity ... Mounjaro is a GLP-1 and GIP receptor agonist. Ozempic acts only on GLP-1. Mounjaro lowers fasting and ...

(HealthDay News) — Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize risks for complications, according to a study presented ...

Eli Lilly has launched Mounjaro in India, a new once-weekly injectable drug for type 2 diabetes and weight management. Approved by CDSCO, it targets GIP and GLP-1 receptors, aiming to improve ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...